Form D · Biotechnology

Oncospace, Inc.

Baltimore, MD · CIK 0001773640

Offering snapshot reported May 15, 2019 · SEC filing

Reported sold
$900K
Offering amount: $1.5M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 26, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$450K$900KApr 11, 2019: $675,000.00Apr 11, 2019May 15, 2019: $900,000.00May 15, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$675,000 → $900,000
  • Reported investors9 → 11

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 15, 2019Amendment$900,000$225,000vs Apr 11, 201911SEC filing
Apr 11, 2019Initial$675,000No comparison9SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-337126

Source: Form D, filed May 15, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Todd Mc Nutt Director, Executive
Daniel Roche Director
Praveen Sinha Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1812 Ashland Avenue Suite 100
Baltimore, MD, 21205